Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Ramakrishnan S., Nicolau DV., Langford B., Mahdi M., Jeffers H., Mwasuku C., Krassowska K., Fox R., Binnian I., Glover V., Bright S., Butler C., Cane JL., Halner A., Matthews PC., Donnelly LE., Simpson JL., Baker JR., Fadai NT., Peterson S., Bengtsson T., Barnes PJ., Russell REK., Bafadhel M.

DOI

10.1016/s2213-2600(21)00160-0

Type

Journal article

Journal

The Lancet Respiratory Medicine

Publisher

Elsevier BV

Publication Date

07/2021

Volume

9

Pages

763 - 772

Permalink Original publication